XML 91 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2013
Accounting Policies [Abstract]  
Schedule of accounts, notes, loans and financing receivable
Activity within the Company’s allowance for doubtful accounts for the periods presented is as follows:
 
2013
 
2012
 
2011
Beginning balance
$
929

 
$
623

 
$
592

Additions to sales allowance and bad debt expense
1,305

 
536

 
276

Deductions (write-offs/recoveries) from reserve
(529
)
 
(230
)
 
(245
)
Ending balance
$
1,705

 
$
929

 
$
623

Summary of product warranty activity
The following table summarizes product warranty activity during 2013 and 2012:
 
2013
 
2012
Beginning balance
$
814

 
$
933

Charges to expense
1,457

 
419

Costs incurred
(1,002
)
 
(538
)
Ending balance
$
1,269

 
$
814

Revenue and related development costs, customer-funded research and development costs
Revenue and related development costs from customer-funded research and development are as follows:
 
Year Ended December 31,
 
2013
 
2012
 
2011
Customer-funded service sales
$
10,302

 
$
5,470

 
$
1,061

Customer-funded costs included in costs of service sales
2,387

 
3,424

 
412

Schedule of reconciliation of basic and diluted weighted average common shares outstanding
A reconciliation of the basic and diluted weighted average common shares outstanding is as follows:
 
2013
 
2012
 
2011
Weighted average common shares outstanding—basic
15,144

 
14,777

 
14,768

Dilutive common shares issuable in connection with stock plans
197

 
242

 
304

Weighted average common shares outstanding—diluted
15,341

 
15,019

 
15,072